Trending Now

Blogger Themes

Menu
Follow Us:
Search
Headline
WPBeginner Spotlight: September 2026 – The Month AI Became Your Site Manager
Jio Platforms Sets the Stage for India’s Largest-Ever IPO: A Watershed Moment for the Nation’s Capital Markets
Google Play Store Expands Beyond Apps: New ‘Shop Devices’ Feature Lets Users Buy Pixel and Samsung Galaxy Hardware Directly
High-Stakes Espionage and Corporate Warfare: OpenAI Alleges Trade Secret Theft by Returning Apple Employee
Beyond the Stream Deck: Why OBS Studio is the Ultimate Productivity Utility for Non-Streamers
Beyond the Smartphone: Is Nothing Expanding Too Quickly Into Wearables with Upcoming Smart Glasses?
Google Ads Introduces Granular Control: New Channel Prioritization and Budget Allocation Features Give Advertisers Reins Over AI-Driven Campaigns
Critical Zero-Day Vulnerability in Ivanti Connect Secure Triggers Urgent CISA Warning and Active In-the-Wild Exploitation
Silicon Trojan Horses: Inside the North Korean "Laptop Farm" Scheme Targeting U.S. Corporate Infrastructure

Tag: pharmeasy

Tech Policy and Regulation
Jia Lissa

PharmEasy Parent API Holdings Narrows FY26 Net Loss by 67% to Rs 520 Crore on Margin-Led Pivot and Quick Commerce Push

NEW DELHI — In a resounding turnaround for India’s heavily scrutinized healthtech sector, API Holdings—the parent entity of leading digital healthcare platform PharmEasy—has reported a monumental 67% reduction in its consolidated net loss for the financial year ended March 2026 (FY26). According to the company’s recently released annual report, net losses plummeted to Rs 520 […]

Back To Top